David D Stenehjem (David Stenehjem)

Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 16

Top Topics

Locally Advanced

Metastatic Renal Cell Carcinoma

Prognostic Factors

Electronic Health Record

Top Venues

Current medical research and opinion

Pharmacogenomics

Future oncology (London, England)

Breast cancer research and treatment

This page only lists publications with an associated author ORCID identifier.

Publications

Chia Jie Tan, Sabrina Ilham, Connor Willis, Ashley Kim, Ze Cong, Diana Brixner, David D Stenehjem
Modeling the population health impact of incorporating a multi-cancer early detection (MCED) test to existing cancer screening among immunocompromised individuals. Current medical research and opinion (2024)
Connor Willis, Chia Jie Tan, Anindit Chhibber, Alexandre H Watanabe, Clara Lam, Sandhya Mehta, Jackie Kwong, Leah Park, Melissa Pavilack-Kirker, Xiaoqing Xu, Kristen Kelley, David D Stenehjem
Patient characteristics and treatment patterns of patients with locally advanced or metastatic HER2-low breast cancer, a single site descriptive study. Breast cancer research and treatment (2024)
Chia Jie Tan, Sabrina Ilham, Connor Willis, Ashley Kim, Ze Cong, Diana Brixner, David D Stenehjem
Modeling the population health impact of incorporating a multi-cancer early detection (MCED) test to existing cancer screening among immunocompromised individuals. Current medical research and opinion 40 (9) (2024)
Chia Jie Tan, Sabrina Ilham, Connor Willis, Ashley Kim, Ze Cong, Diana Brixner, David D Stenehjem
Modeling the population health impact of incorporating a multi-cancer early detection (MCED) test to existing cancer screening among immunocompromised individuals. Current medical research and opinion 40 (9) (2024)
Trang H Au, Connor Willis, Maija Reblin, Katherine B Peters, Phioanh Leia Nghiemphu, Jennie W Taylor, Howard Colman, Adam L Cohen, David Ryan Ormond, Elizabeth C Neil, Arnab Chakravarti, Nicole Willmarth, Bea Christine Balajonda, Jyothi Menon, Junjie Ma, Hillevi Bauer, Ryan S Nelson, Malinda S Tan, Prianka Singh, Alexander Marshall, Beata Korytowsky, David D Stenehjem, Diana Brixner
Caregiver survey in glioblastoma focused on cognitive dysfunction: development and results from a multicenter study. Future oncology (London, England) (2023)
Tiana S Luczak, Jacob T Brown, Pamala A Jacobson, David D Stenehjem
Perceptions of pharmacogenetic exceptionalism and the implications for clinical management within an electronic health record. Clinical and translational science 15 (9) (2022)
Eman Biltaji, Brandon Walker, Trang H Au, Zachary Rivers, Jennifer Ose, Christopher I Li, Diana I Brixner, David D Stenehjem, Cornelia M Ulrich
Can Cost-effectiveness Analysis Inform Genotype-Guided Aspirin Use for Primary Colorectal Cancer Prevention? Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 30 (6) (2021)
Jeffrey R Bishop, R Stephanie Huang, Jacob T Brown, Pawel Mroz, Steven G Johnson, Josiah D Allen, Suzette J Bielinski, Julie England, Joel F Farley, David B Gregornik, Jyothsna Giri, Christine Kroger, Susie E Long, Tiana S Luczak, Erin J McGonagle, Sisi Ma, Eric T Matey, Pinar K Mandic, Ann M Moyer, Wayne T Nicholson, Natasha J Petry, Pamala A Pawloski, Allyson Schlichte, Stephen W Schondelmeyer, Randall D Seifert, Marilyn K Speedie, David D Stenehjem, Robert J Straka, Jason Wachtl, Stephen C Waring, Brian Van Ness, Heather A Zierhut, Constantin Aliferis, Susan M Wolf, Catherine A McCarty, Pamala A Jacobson
Pharmacogenomics education, research and clinical implementation in the state of Minnesota. Pharmacogenomics 22 (11) (2021)
David D Stenehjem, Solomon Lubinga, Keith A Betts, Wenxi Tang, Mads Jenkins, Yong Yuan, John Hartman, Sumati Rao, Jenny Lam, David Waterhouse
Treatment patterns in patients with metastatic non-small-cell lung cancer in the era of immunotherapy. Future oncology (London, England) 17 (22) (2021)
Tiana S Luczak, Sarah Jane Brown, Danielle Armbruster, Megan Hundertmark, Jacob T Brown, David D Stenehjem
Strategies and settings of clinical pharmacogenetic implementation: a scoping review of pharmacogenetics programs. Pharmacogenomics 22 (6) (2021)
Jacob T Brown, Dannielle A Macdonald, Ann Yapel, Tiana S Luczak, Anna Hanson, David D Stenehjem
Integrating pharmacogenetic testing via medication therapy management in an outpatient family medicine clinic. Pharmacogenomics 22 (4) (2021)
David D Stenehjem, Claire Telford, Sudhir K Unni, Hillevi Bauer, Amy Sainski, Rishi Deka, Marisa B Schauerhamer, Xiangyang Ye, Casey R Tak, Junjie Ma, Tapashi B Dalvi, Lia Gutierrez, James A Kaye, Jerzy E Tyczynski, Diana I Brixner, Joseph E Biskupiak
BRCA testing and outcomes in women with breast cancer. Breast cancer research and treatment 186 (3) (2021)
Megan E Hundertmark, Stephen C Waring, David D Stenehjem, Dannielle A Macdonald, David J Sperl, Ann Yapel, Jacob T Brown
Pharmacist's attitudes and knowledge of pharmacogenomics and the factors that may predict future engagement. Pharmacy practice 18 (3) (2020)
Jason I Griffiths, Pierre Wallet, Lance T Pflieger, David D Stenehjem, Xuan Liu, Patrick A Cosgrove, Neena A Leggett, Jasmine A McQuerry, Gajendra Shrestha, Maura Rossetti, Gemalene Sunga, Philip J Moos, Frederick R Adler, Jeffrey T Chang, Sunil Sharma, Andrea H Bild
Circulating immune cell phenotype dynamics reflect the strength of tumor-immune cell interactions in patients during immunotherapy. Proceedings of the National Academy of Sciences of the United States of America 117 (27) (2020)
David D Stenehjem, Andrew W Hahn, David M Gill, Daniel Albertson, Banumathy Gowrishankar, Joseph Merriman, Archana M Agarwal, Venkata Thodima, Erik B Harrington, Trang H Au, Benjamin L Maughan, Jane Houldsworth, Sumanta K Pal, Neeraj Agarwal
Predictive genomic markers of response to VEGF targeted therapy in metastatic renal cell carcinoma. PloS one 14 (1) (2019)
G Weldon Gilcrease, David D Stenehjem, Mark L Wade, John Weis, Kimberly McGregor, Jonathan Whisenant, Kenneth M Boucher, Kelli Thorne, Nicole Orgain, Ignacio Garrido-Laguna, Sunil Sharma
Phase I/II study of everolimus combined with mFOLFOX-6 and bevacizumab for first-line treatment of metastatic colorectal cancer. Investigational new drugs 37 (3) (2018)